CRAIG WEISE: Open Payments
NPI 1215133509 · NEWARK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,531 in 79 payments from 12 companies in 2025. Trend: 2023 $979 · 2024 $1,152 · 2025 $1,531
Food & beverage: $1,438Education: $93
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $463 |
| Janssen Biotech, Inc. | 12 | $334 |
| PFIZER INC. | 8 | $192 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $138 |
| Ardelyx, Inc. | 5 | $101 |
| Phathom Pharmaceuticals, Inc. | 6 | $88 |
| Lilly USA, LLC | 4 | $67 |
| Madrigal Pharmaceuticals | 3 | $49 |
| Sandoz Inc. | 2 | $38 |
| Gilead Sciences, Inc. | 2 | $32 |
Products named: TREMFYA, RINVOQ, VELSIPITY, IBSRELA, VOQUEZNA, ENTYVIO, SKYRIZI, OMVOH.
Industry payments across NY — which companies pay providers there.
